Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for tamoxifen-associated cognitive side effects in postmenopausal women with ER-positive breast cancer
NL-OMON43176Phase 2Not yet recruiting
- Sponsor
- Limoxifen
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of guanfacine in breast cancer (2 arms), sponsored by Limoxifen. Planned start Mar 2016; status: not yet recruiting.
02
Drugs
guanfacine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON43176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43176.